Digestive System Diseases

633 trials 301 recruiting

Filter these 633 trials by phase, country and sponsor.

Open in Search →

Effect of low-dose Interferon-alfa2a on perioperative immune suppression Recruiting

2024-517619-65-00 Colon cancer 4 2023-08-28
The iCaD Study Recruiting

2022-503026-12-00 Immune checkpoint inhibitor related colitis 5 2023-08-22
Continuing Somatostatin Analogues Upon progression in Neuroendocrine tumour pAtients (SAUNA trial) Recruiting

2022-502703-30-00 neuroendocrine tumours 6 2023-06-28
Clinical study in adults and young patients with Primary Sclerosing Cholangitis treated with oral vancomycin or placebo Recruiting

2023-507425-42-00 Primary Sclerosing Cholangitis 4 2023-06-15
Interest of systematic treatment with PPI after endoscopic myotomy compared to PPI treatment in case of symptoms in prevention of gastroesop… Recruiting

2022-500218-25-01 esophageal achalasia 6 2023-06-01
Multicenter randomized controlled clinical trial comparing ebastine and mebeverine as treatment of irritable bowel syndrome Recruiting

2022-501780-41-00 Irritable Bowel Syndrome 5 2023-05-17
A Long-term Study in Children and Teenagers with Ulcerative Colitis or Crohn’s Disease treated with Vedolizumab IV Recruiting

2023-509046-36-00 Active Ulcerative Colitis (UC) or Crohn's disease (CD) 5 2023-04-26
An European multinational study of a personalized approach of human albumin administration in patients with cirrhosis of the liver and compl… Recruiting

2022-501006-34-01 Liver cirrhosis 5 2023-03-29
PREPARE - Intrapapillary botulinum toxin injection for PREvention of post-surgical PAncREatic fistula Recruiting

2024-514929-33-00 PANCREATIC FISTULA 5 2023-03-27
(SPARROW) Standard versus Pre-emptive Antibiotic Treatment to Reduce the Rate of Infectious Outcomes after Whipple’s procedure (SPARROW): a … Recruiting

2024-510766-16-00 Pancreatoduodenectomy with a high risk for contaminated 11 2023-03-06
A Phase 2B Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Namodenoson in the Treatment of Non-Alcoholic St… Recruiting

2023-510548-19-00 Non-Alcoholic Steatohepatitis (NASH) with F1-3 fibrosis 4 2023-03-02
A Trial to Evaluate EP 104GI in Adults with Eosinophilic Esophagitis (EoE) (RESOLVE) Recruiting

2024-516689-13-00 Eosinophilic esophagitis 9 2023-02-06
Preoperative treatment with mFOLFIRINOX (or Gem-Nab-P) +/- isotoxic high-dose Stereotactic Body Radiation Therapy (iHD-SBRT) for borderline … Recruiting

2022-501181-22-01 Pancreatic adenocarcinoma 4 2023-02-06
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in multimodal therapy for patients with oligometastatic peritoneal gastric cancer: … Recruiting

2024-515981-14-00 Gastric adenocarcinoma with peritoneal metastases 5 2022-12-14
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants with Ulcerative Colitis or Crohn’s Disease (SHINE-ON) Recruiting

2023-506239-14-00 Crohn’s Disease 5 2022-12-13
Cholangiocarcinoma treatment with radiofrequency ablation or photodynamic therapy Recruiting

2022-500107-50-00 hilar cholangiocarcinoma 6 2022-10-12
TERTIO : Evaluation de l’intérêt de combiner un vaccin inducteur de CD4-Th1 dérivé de la télomérase avec un traitement par atezolizumab et b… Recruiting

2022-500643-20-00 Patients with locally advanced, metastatic or unresecta 4 2022-09-27
EVIDENT Recruiting

2023-510092-62-00 Colorectal cancer 4 2022-09-27
Prevention of postoperative endoscopic disease recurrence in Crohn’s disease: a multicentric study that compares the systematic start of bio… Recruiting

2022-500311-39-00 Patients with Crohn's disease undergoing surgery and ha 6 2022-09-08
A trial to compare efficacy and tolerability of Plenvu® and Picoprep® as cleansing agents of the large bowel before colonoscopy (examination… Recruiting

2024-518544-21-00 The trial is about comparing the efficacy of Plenvu wit 6 2022-09-01
HIsTological and CLinical effects of Imipramine in the treatment of patients with cancer over-expressing Fascin1. (HITCLIF) Recruiting

2023-504943-15-00 Cancer(colon cancer stage II-III, rectal cancer, and br 4 2022-08-19
A study to evaluate efficacy and safety of an investigational drug named volixibat in patients with itching caused by primary biliary cholan… Recruiting

2023-504660-41-00 Cholestatic Pruritus in Patients with Primary Biliary C 4 2022-07-11
Multicenter, randomized, double-blind, comparative clinical trial to assess the efficacy of Zinc Acexamate versus a placebo in improving the… Recruiting

2024-518242-24-00 Chronic liver disease 5 2022-06-27
Short bowel syndrome and study of the absorption of antibiotics with good oral bioavailability Recruiting

2024-515136-72-00 Patient with short bowel syndrome treated with antibiot 6 2022-06-17